GJQ-51259-71901
3 vaccinations
2 coded responses
7 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 191 / PA
- Registered
- 2022-06-23
- Relationship
- Child or adolescent in my care
- Guardian
- 8RN-14603-46356
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-23
Registered in v-safe
-
2022-09-26
Dose 1 — Pfizer-BioNTechCo-administered: Hepatitis A
-
2022-11-14
Dose 2 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-30
- 2022-12-05
-
2022-12-12
Survey response — day 28, dose 2, under 3MedDRA: Cough, Diarrhoea, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Mild runny nose, cough, and diarrheaMedDRA releases: 2024-11 · check-in free text available
- 2022-12-19
- 2022-12-26
-
2023-01-09
Dose 3 — Pfizer-BioNTech
-
2023-02-13
Survey response — 3 months, dose 2, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-26 | Pfizer-BioNTech | Hepatitis A |
| 2 | 2022-11-14 | Pfizer-BioNTech | Flu |
| 3 | 2023-01-09 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Mild runny nose, cough, and diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release